Bacil Pharma Ltd Share Price Today - Bacil Pharma Ltd Stock Price Live NSE/BSE

Bacil Pharma Ltd

NSE: BSE: 524516

₹48.10

(-5.00%)

Sun, 15 Mar 2026, 00:46 pm

MTF 5xInvest in Bacil Pharma Ltd with 5x Leverage Buy with MTF

Market Cap726.69M

PE Ratio40.10

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Bacil Pharma Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
67.79
Net Profit
0.40
P/B
2.33
Sector P/E
40.12
P/E
146.52
EV/EBITDA
145.73
Debt/Equity (Industry)
0.16
Interest Cover (Industry)
20.07
ROCE (Industry)
20.49
RONW (Industry)
17.59
ROE
-0.98
ROCE
-1.04
Debt/Equity
0.01
EPS (TTM)
0.51
Dividend Yield
0
Book Value
18.63
Interest Cover
0

Analysis

all

Pros

Debt is covered by short term assets, assets are 4x debt.
Bacil Pharma's level of debt (5.8%) compared to net worth is satisfactory (less than 40%).
Low level of unsold assets.
The average tenure for the Bacil Pharma board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Manmohan's remuneration is lower than average for companies of similar size in India.

Cons

Unable to evaluate Bacil Pharma's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Bacil Pharma's dividend against the top 25% market benchmark as the company has not reported any payouts.
Bacil Pharma's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
Operating cash flow is negative therefore debt is not well covered.
Bacil Pharma's long term commitments exceed its cash and other short term assets.

Financials

No Result Found

Ratios

No Result Found

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	0.08	0.08	0.20	0.20	10.60
FII	0	0	0	0	0
DII	0	0	0	0	0
Public	99.92	99.92	99.80	99.80	89.40
Government	0	0	0	0	0

Technical Analysis

RSI

MACD

50 DMA

200 DMA

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	-	-	-	-	-	-	-
Fibonacci	-	-	-	-	-	-	-
Camarilla	-	-	-	-	-	-	-

Pivots Level: Classic

Pivot Point

LTP: -

Moving Average

SMAEMA

Period

Value

10-EMA
-
20-EMA
-
30-EMA
-
50-EMA
-
100-EMA
-
200-EMA
-

Announcement Date	Purpose	Action
13 Feb 2026	board-meetings	Quarterly Results
13 Nov 2025	board-meetings	Quarterly Results, Half Yearly Results
12 Sept 2025	agm
22 Oct 2024	egm
09 Sept 2024	agm
24 Aug 2023	agm
09 Sept 2022	agm
01 Sept 2021	agm

Peer Comparison

No Result Found

Bacil Pharma Ltd

Cipla Ltd

Dr Reddys Laboratories Ltd

Divis Laboratories Ltd

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd

Bacil Pharma Ltd About

Bacil Pharma main object of the Company is to undertake Pharmaceutical business.

Industry

Pharmaceuticals - Indian - Bulk Drugs

Founded

1987

Headquarters

CEO

Employees

Contact

Website

http://www.bacilpharma.co.in

bacilpha@yahoo.com

Phone

Location

G2 & G3 Samarpan Complex, chakala Andheri East, Mumbai, Maharashtra, 400099

Year	History
1987	Bacil Pharma Ltd was incorporated as a P Ltd company in the State of Maharashtra.
1990	The company was converted into a public Ltd company.
1993	The company obtained a fresh certificate of incorporation consequent to the change of name.
2008	Bacil Pharma provided an E-mail ID for Investor Grievances.

Client Name	Order Side	QTY	Avg Price	Date
BULL BEAR TRADERS	Sell	120089	38.27	29 Oct 2025
AKARSHIKA TRADERS LLP	Buy	144000	38.32	29 Oct 2025
PASHUPATI CAPITAL SERVICE PVT LTD	Sell	236244	40.61	28 Oct 2025
AKARSHIKA TRADERS LLP	Buy	100000	40.74	28 Oct 2025
PASHUPATI CAPITAL SERVICE PVT LTD	Sell	139435	39.01	27 Oct 2025
YOGESH PRASANLAL DAGLI	Sell	80000	35.71	04 Aug 2025
PASHUPATI CAPITAL SERVICE PVT LTD	Buy	100000	35.71	04 Aug 2025
HEMENDRA RATILAL MEHTA	Sell	40005	42.43	02 Apr 2025
PASHUPATI CAPITAL SERVICE PVT LTD	Buy	30355	42.28	02 Apr 2025
SANMITRA COMMERCIAL LTD.	Sell	36000	42	27 Mar 2025

Bacil Pharma Ltd News

Bacil Pharma Clarifies Price Movement to BSE

Bacil Pharma Limited responds to BSE clarification request on February 24, 2026, stating no unpublished price sensitive information behind recent stock price movements, attributing fluctuations to market forces.

24 Feb 2026

stocks

Norbexi Industries Exits Bacil Pharma Stake

Norbexi Industries Limited has completely divested its 14.46% stake in Bacil Pharma Limited through an off-market transaction, reducing its holding from 2,075,000 shares to zero.

23 Feb 2026

co actions results

Bacil Pharma Q3FY26 Results: Profit Jumps to ₹3.92L

Bacil Pharma reported Q3FY26 profit of ₹3.92 lakhs vs loss of ₹6.20 lakhs in Q3FY25. Nine-month profit surged to ₹72.17 lakhs from ₹38.81 lakhs YoY.

13 Feb 2026

co actions results

Khem-Sum Apparels Sells Entire Bacil Pharma Stake

Khem-Sum Apparels Overseas Ltd. has disposed of its complete 200-share holding in Bacil Pharma Limited through an off-market sale on December 29, 2025, reducing its stake from 0.001% to zero.

30 Dec 2025

co actions results

Bacil Pharma Promoter Suman P. Shah Sells Shares

Suman P. Shah, a promoter of Bacil Pharma Limited, disposed of 500 equity shares through market sale on December 24, 2025, reducing his holding to zero shares.

29 Dec 2025

co actions results

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800

Bacil Pharma Ltd

Bacil Pharma Share Price Live Chart

Summary

Analysis

Financials

Ratios

Shareholding

Technical Analysis

Corporate Actions

Peer Comparison

Bacil Pharma Ltd About

Contact

Bacil Pharma Ltd Company History

Deals

Bacil Pharma Ltd News